8-K: Village Farms International Reports Strong Q1 2024 Results, Driven by Canadian Cannabis Growth

Village Farms International saw a 21% increase in total sales and a significant improvement in adjusted EBITDA in the first quarter of 2024, driven by strong performance in its Canadian cannabis business.

Summary

• Village Farms International reported a 21% increase in consolidated sales, reaching $78.1 million in the first quarter of 2024, compared to $64.7 million in the same period last year.
• The company's net loss improved to ($2.9 million), or ($0.03) per share, from a loss of ($6.6 million), or ($0.06) per share, year-over-year.
• Adjusted EBITDA saw a six-fold increase to $3.6 million, up from $0.5 million in the first quarter of 2023.
• Canadian cannabis sales surged by 49% to $37.4 million (C$50.5 million), with retail branded sales growing 28% organically.
• The Canadian cannabis business achieved positive adjusted EBITDA of $4.1 million (C$5.5 million) and positive free cash flow.
• Village Farms' fresh produce business also showed improvement, with sales increasing by 4% to $36.1 million and a net income of $0.1 million.
• The company's U.S. cannabis business, Balanced Health Botanicals, experienced a slight decrease in net sales to $4.5 million, with a net loss of ($0.7 million).
• Village Farms is expanding its international cannabis operations, with a production facility in the Netherlands expected to start production in the fourth quarter of 2024.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong growth in key areas, particularly Canadian cannabis, and significant improvements in profitability metrics. While there are some challenges in the US market, the overall tone is optimistic and suggests a positive trajectory for the company.

Positives

• The company experienced significant growth in Canadian cannabis sales, with a 49% increase year-over-year.
• The Canadian cannabis business achieved profitability and positive free cash flow.
• The fresh produce segment returned to profitability with a 4% increase in sales and improved EBITDA.
• Village Farms is expanding its international cannabis operations, with a new facility in the Netherlands.
• The company's Renewable Natural Gas Project is now operational and contributing to profitability.
• Village Farms is gaining market share in the Canadian cannabis market, becoming the second largest national market share holder.
• The company has launched innovative products like Hi-Def Pre-Rolls, which are exceeding initial demand.

Negatives

• The U.S. cannabis business, Balanced Health Botanicals, experienced a decrease in net sales and a net loss.
• The gross margin for Canadian cannabis decreased to 25% from 34% due to sales of non-brand-spec inventory.
• The company still reported a consolidated net loss of $2.9 million, although it is an improvement year-over-year.

Risks

• The company faces risks related to the cannabis and cannabinoids industry, including regulatory compliance and market volatility.
• There are risks associated with integrating acquisitions like Balanced Health and Rose LifeScience.
• The company is dependent on credit facilities and may face difficulties in obtaining additional financing.
• The company is vulnerable to rising energy costs and inflationary effects on cultivation and transportation costs.
• The company faces competition in the cannabis and produce markets.
• The company's application for a Texas medicinal marijuana license is still pending review.

Future Outlook

The company expects to start production in its first facility in the Netherlands in the fourth quarter of 2024 and anticipates benefiting from recent investments in cultivation technologies, including artificial intelligence. They also expect continued growth in their Canadian export business.

Management Comments

• Michael DeGiglio, President and Chief Executive Officer, stated that the first quarter was an especially strong start to 2024, with Canadian Cannabis retail branded sales growing 28% year-over-year.
• He also noted the company's success in quality, innovation, and brand building, which are driving results.
• DeGiglio highlighted the company's position to leverage its cannabis expertise for new market opportunities around the world.

Industry Context

This announcement reflects the ongoing growth and evolution of the cannabis industry, particularly in Canada, where Village Farms is establishing itself as a major player. The company's expansion into international markets, such as the Netherlands, also aligns with the broader trend of global cannabis legalization and market development. The company's success in the Canadian market positions them well to take advantage of the emerging US market.

Comparison to Industry Standards

• Village Farms' 28% organic growth in Canadian cannabis retail sales is a strong performance compared to other licensed producers (LPs) in Canada.
• The company's achievement of the number two national market share position in the pre-roll category and the number one position in dried flower demonstrates its competitive strength.
• The company's ability to regain the top market share position in Ontario, Canada's largest provincial market, is a significant achievement.
• The six-fold increase in adjusted EBITDA to $3.6 million is a substantial improvement compared to the previous year, indicating improved operational efficiency.
• While the company's U.S. cannabis business is not performing as well as the Canadian business, the company is taking steps to improve its performance, such as internalizing gummy production.

Management Changes

Stakeholder Impact

• Shareholders will likely view the improved financial results and growth prospects positively.
• Employees may benefit from the company's growth and expansion.
• Customers will benefit from the company's focus on quality and innovation.
• Suppliers may see increased business opportunities with the company's growth.
• Creditors may view the company's improved financial performance favorably.

Next Steps

• The company plans to start production at its first facility in the Netherlands in the fourth quarter of 2024.
• The company will continue to expand its market share in the Canadian cannabis market.
• The company will continue to evaluate other uses for its Monahans greenhouse facility.
• The company will continue to work on its application for a Texas medicinal marijuana license.
• The company will continue to focus on its fresh produce business and implement new cultivation technologies.

Key Dates

Keywords

cannabis, fresh produce, adjusted EBITDA, market share, Canadian cannabis, net sales, profitability, greenhouse, international cannabis, renewable natural gas